Skip to the page

Data / Form D filings / Willow Life Sciences, Inc.

Willow Life Sciences, Inc.: Form D filing

Willow Life Sciences, Inc., a health care company in Allston, MA, filed a Form D with the SEC in 2025. The latest, on November 6, 2025, reports $4 million sold of a $4 million offering to 19 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
127 WESTERN AVENUE, Allston, MA, 02134
Phone
(765) 212-9972
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2083161

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 6, 2025New notice$4,000,000$4,000,00019May 29, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Catherine TadinaDirector
Mariia GrebenshchikovaDirector
Morgan MoncadaExecutive Officer, Director

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Nov 3, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Willow Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.